Table 1.
Patient demographics/treatment
Age, years | Gender | Site | Stage | Metastasis | Previous TXT | Duration anti-PD-L1, months |
---|---|---|---|---|---|---|
48 | m | prostate | IV | bone, lymph nodes | radiation | 4 |
66 | m | lung | III | adjuvant | cisplatin/Alimta | 4 |
72 | m | lung | III | adjuvant | carboplatin/Taxol | 10 |
59 | m | lung | IV | lung | na | 4 |
69 | m | lung | IV | lung | carboplatin/Etopophos | 9 |
71 | m | urothel | IV | lymph nodes | na | 4 |